Mostrar el registro sencillo del documento

dc.rights.licenseAtribución-NoComercial-SinDerivadas 4.0 Internacional
dc.contributor.advisorMora Pabón, Guillermo
dc.contributor.authorBastidas Narváez, Andrea Milena
dc.date.accessioned2022-08-18T16:37:41Z
dc.date.available2022-08-18T16:37:41Z
dc.date.issued2022-08-15
dc.identifier.urihttps://repositorio.unal.edu.co/handle/unal/81950
dc.descriptionilustraciones, graficas
dc.description.abstractIntroducción. Actualmente, los dispositivos electrónicos cardiovasculares implantables se convirtieron en el pilar fundamental del tratamiento de pacientes con arritmias, sin embargo, una de las complicaciones asociadas a su uso consiste la infección, su presencia es equivalente a mayor morbilidad y mortalidad. El objetivo principal de este estudio es evaluar el desempeño pronóstico del score PADIT, escala diseñada para identificar a pacientes con riesgo de infección. Métodos. Se realizó un estudio observacional con componente analítico de cohorte retrospectiva en pacientes atendidos en los últimos 6 años en el servicio de electrofisiología. En el Hospital Universitario Clínica San Rafael se atendieron 3745 pacientes portadores de dispositivos electrónicos implantables cardiacos en el periodo descrito. En el estudio se recogió datos de 1780 pacientes, teniendo en cuenta los criterios de inclusión y exclusión. Resultados. De los pacientes incluidos 953 (54%) fueron de género masculino y 827 (46%) de femenino, la edad predominante fue mayor de 69 años; se encontraron diferentes variables relacionadas con infección, como la edad (p=0,01), el antecedente de insuficiencia cardiaca (p=0,007), el ingreso hospitalario reciente (p=0,000), el tipo de intervención (p=0,013), entre otros. Al realizar el índice de Youden, se encontró con un índice de confianza del 95%, que el score PADIT tiene un área bajo la curva mayor a 0,5 en las tres puntuaciones de riesgo (bajo, moderado y alto). Conclusiones. Se concluye que el score PADIT tiene desempeño regular en la predicción de infección en la población analizada. (Texto tomado de la fuente)
dc.description.abstractIntroduction. Currently, implantable cardiovascular electronic devices have become the mainstay of treatment for patients with arrhythmias, however, one of the complications associated with their use is infection, their presence is equivalent to increased morbidity and mortality. The main objective of this study is to evaluate the prognostic performance of the PADIT score, a scale designed to identify patients at risk of infection. Methods. An observational study with an analytical component of a retrospective cohort was carried out in patients treated in the last 6 years in the electrophysiology service. At the Hospital Universitario Clinical San Rafael, 3,745 patients with cardiac implantable electronic devices were treated in the period described. The study collected data from 1,780 patients, taking into account the inclusion and exclusion criteria. Results. Of the patients included, 953 (54%) were male and 827 (46%) female, the predominant age was over 69 years; different variables related to infection were found, such as age (p=0.01), history of heart failure (p=0.007), recent hospital admission (p=0.000), type of intervention (p=0.013), among others. When performing the Youden index, it was found with a confidence index of 95%, that the PADIT score has an area under the curve greater than 0.5 in the three risk scores (low, moderate and high). Conclusions. It is concluded that the PADIT score has regular performance in predicting infection in the analyzed population.
dc.format.extent70 páginas
dc.format.mimetypeapplication/pdf
dc.language.isospa
dc.publisherUniversidad Nacional de Colombia
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subject.ddc610 - Medicina y salud::616 - Enfermedades
dc.subject.otherDispositivos electrónicos cardíacos implantables (CIED)
dc.subject.othermarcapasos (PPM)
dc.subject.otherDesfibriladores automáticos implantables (DCI)
dc.titleEvaluación pronóstica del score PADIT para la predicción de infección asociada a dispositivos cardíacos implantables en población colombiana
dc.typeTrabajo de grado - Especialidad Médica
dc.type.driverinfo:eu-repo/semantics/masterThesis
dc.type.versioninfo:eu-repo/semantics/acceptedVersion
dc.publisher.programBogotá - Medicina - Especialidad en Medicina Interna
dc.contributor.educationalvalidatorRojas Ruiz Ingrid Tatiana
dc.contributor.researcherGarcía Moncayo, Andrea Lorena
dc.description.degreelevelEspecialidades Médicas
dc.description.degreenameEspecialista en Medicina Interna
dc.description.methodsEstudio observacional analítico de cohorte retrospectiva
dc.identifier.instnameUniversidad Nacional de Colombia
dc.identifier.reponameRepositorio Institucional Universidad Nacional de Colombia
dc.identifier.repourlhttps://repositorio.unal.edu.co/
dc.publisher.departmentDepartamento de Medicina Interna
dc.publisher.facultyFacultad de Medicina
dc.publisher.placeBogotá, Colombia
dc.publisher.branchUniversidad Nacional de Colombia - Sede Bogotá
dc.relation.indexedRedCol
dc.relation.indexedLaReferencia
dc.relation.referencesArber N, P. E. (1994). Pacemaker endocarditis. Report of 44 cases and review of the literature. Medicine (Baltimore) , 73:299
dc.relation.referencesBaddour Larry M., A. E. (2010). Update on Cardiovascular Implantable Electronic Device Infections and Their Management. Circulation, 121:458–477
dc.relation.referencesBaddour LM, C. Y. (2012). Clinical practice. Infections of cardiovascular implantable electronic devices. N Engl J Med , 367:842
dc.relation.referencesBaddour LM, W. W. (2005). Infections of prosthetic valves and intravascular devices. Principles and Practice of Infectious Diseases, 6th ed, Mandell GL, Bennett JE, Dolin R (Eds), Churchill Livingstone, Philadelphia , 102
dc.relation.referencesBongiorni MG, B. H. (2018). ESC Scientific Document Group. 2018 EHRA expert consensus statement on lead extraction: recommendations on definitions, endpoints, research trial design, and data collection requirements for clinical scientific studies and registries: endorsed by APHRS/HR. Europace , 20: 1217–1217
dc.relation.referencesC., D. D. (2018). Approach to Diagnosis of Cardiovascular Implantable-Electronic-Device Infection. Journal of Clinical Microbiology, volume 56, Issue 7
dc.relation.referencesCacoub P, L. P. (1998). Pacemaker infective endocarditis. . Am J Cardiol , 82:480.
dc.relation.referencesCarina, B.-L. (2020). European Heart RhythmAssociation (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections. European Heart Journal, 41, 2012–2032.
dc.relation.referencesChua JD, W. B. (2000). Diagnosis and management of infections involving implantable electrophysiologic cardiac devices. Ann Intern Med, 133:604
dc.relation.referencesDa Costa A, L. H. (1998). Role of the preaxillary flora in pacemaker infections. Circulation, 97:1791–1795
dc.relation.referencesDai M, C. C. (2019). Trends of Cardiovascular Implantable Electronic Device Infection in 3 Decades: A Population-Based Study. JACC Clin Electrophysiol, 5:1071
dc.relation.referencesDarouiche RO, W. M. (2010 ). Chlorhexidine-Alcohol versus Povidone-Iodine for Surgical-Site Antisepsis. N Engl J Med, 362(1):18-26
dc.relation.referencesDeSimone DC, S. M. (2019). Contemporary management of cardiac implantable electronic device infection. Heart , 105:961
dc.relation.referencesDuval X, S.-S. C. (2004). Endocarditis in patients with a permanent pacemaker: a 1-year epidemiological survey on infective endocarditis due to valvular and/or pacemaker infection. Clin Infect Dis , 39:68
dc.relation.referencesEggimann P, W. F. (2000). Pacemaker and defibrillator infections. In: Infections Associated with Indwelling Medical Devices, Waldvogel FA, Bisno AL (Eds). American Society for Microbiology Press, 247
dc.relation.referencesErba PA, L. P. (2018). Recommendations on nuclear and multimodality imaging in IE and CIED infections. Eur J Nucl Med Mol Imaging , 45:1795–1815
dc.relation.referencesEsquer Garrigos Z, S. M.-Q. (2020). Molecular Approach to Diagnosis of Cardiovascular Implantable Electronic Device Infection. . Clin Infect Dis , 70:898
dc.relation.referencesFozia Z Ahmed, 1. C.-L., & Bloom, H. (2021). Use of healthcare claims to validate the Prevention of Arrhythmia Device Infection Trial cardiac implantable electronic device infection risk score. Europace, 23(9): 1446–1455
dc.relation.referencesGreenspon AJ, P. J. (2011). 16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008. J Am Coll Cardiol, 58:1001
dc.relation.referencesH, B. D. (2019). Risk Factors for Infections Involving Cardiac Implanted Electronic Devices. Journal of the American College of Cardiology, Volume 74, Issue 23, Pages 2845-2854
dc.relation.referencesHabib G, L. P. (2015). ESC Scientific Document Group. 2015 ESC Guidelines for the management of infective endocarditis: the Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: european Association for Cardio-Thoracic. Eur Heart J , 36:3075–3128
dc.relation.referencesHossein Sadeghi, M. (2018). New Insights into Predictors of Cardiac Implantable Electronic Device Infection. Tex Heart Inst J, 45(3): 128–135
dc.relation.referencesHui-Chen Han, H. N. (2021). Epidemiology of cardiac implantable electronic device infections: incidence and risk factors. Europace, 23, iv3–iv10
dc.relation.referencesHussein AA, B. Y. (2016). Microbiology of cardiac implantable electronic device infections. . JACC Clin Electrophysiol , 2:498–505
dc.relation.referencesJN, C. (1994). Pathology of cardiac pacemakers and central catheters. . Curr Top Pathol , 86:199
dc.relation.referencesJorge, C.-P. (2019). Proposal for a Novel Score to Determine the Risk of Cardiac Implantable Electronic Device Infection. Rev Esp Cardiol, Volume 72, Issue 10, Pages 806-812
dc.relation.referencesJoy PS, K. G. (2017). Cardiac implantable electronic device infections: Who is at greatest risk? Heart Rhythm, 14:839
dc.relation.referencesKlug D, B. M. (2007). Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: results of a large prospective study. Circulation, 116:1349
dc.relation.referencesKlug D, L. D. (1997). Systemic infection related to endocarditis on pacemaker leads: clinical presentation and management. Circulation, 95:2098
dc.relation.referencesKnigina L, K. C. (2010). Treatment of patients with recurrent or persistent infection of cardiac implantable electronic devices. . Europace , 12:1275–1281
dc.relation.referencesKrahn Andrew D., Y. L. (2018 ). Prevention of Arrhythmia Device Infection Trial: The PADIT Trial. J Am Coll Cardiol, 72 (24) 3098–3109
dc.relation.referencesKusumoto FM, S. M.-G. (2017). 2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction. Heart Rhythm , 14:e503–e551
dc.relation.referencesKusumoto Fred M, M. H. (2019). Bradycardia Clinical Practice Guidelines. Circulation, 140:e382–e482
dc.relation.referencesLe KY, S. M. (2011). Impact of timing of device removal on mortality in patients with cardiovascular implantable electronic device infections. Heart Rhythm, 8:1678
dc.relation.referencesLebeaux D, F. ́.-H.-M. (2014). Management of infections related to totally implantable venous access ports: challenges and perspectives. Lancet Infect Dis , 14:146–159
dc.relation.referencesLi JS, S. D. (2000). Proposed modifications to the duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis , 30:633–638
dc.relation.referencesM, S. M. (2019). Cardiac Implantable Electronic Device Therapy: Permanent Pacemakers, Implantable Cardioverter Defibrillators, and Cardiac Resynchronization Devices. Med Clin North Am, 103(5):931-943
dc.relation.referencesMittal Suneet, S. R. (2014 ). Cardiac implantable electronic device infections: incidence, risk factors, and the effect of the AigisRx antibacterial envelope. Heart Rhythm, 11(4):595-601
dc.relation.referencesMorishita A, S. T. (2001). Treatment strategy for infections in patients with permanent pacemakers. Journal of Artificial Organs. , 4:193-7
dc.relation.referencesMuhammad Irfan, I. K. (2020). Delays in Temporary and Permanent Pacemakers: Causes and In-Hospital Outcomes. Cureus, 12(2): e6953
dc.relation.referencesMulpuru SK, P. V.-G. (2013). Device infections: management and indications for lead extraction. Circulation , 128:1031
dc.relation.referencesNagpal A, P. R.-Q. (2015). Usefulness of sonication of cardiovascular implantable electronic devices to enhance microbial detection. Am J Cardiol , 115:912
dc.relation.referencesNakajima I, N. R. (2021). Staphylococcus bacteremia without evidence of cardiac implantable electronic device infection. Heart Rhythm , 18:752
dc.relation.referencesOlsen T, J. O. (2019). Incidence of device-related infection in 97 750 patients: clinical data from the complete Danish device-cohort (1982-2018). Eur Heart J, 40:1862
dc.relation.referencesOrtega Calvo Manuel, C. D. (2002). Regresión logística no condicionada y tamaño de muestra: una revisión bibliográfica. Rev. Esp. Salud Pública, 85-93
dc.relation.referencesPatel D, K. F. (2015). Cardiac implantable electronic device lead extraction in patients with underlying infection using open thoracotomy or percutaneous techniques. Cardiol J , 22:68–74
dc.relation.referencesPeacock JE, S. J. (2018). Attempted salvage of infected cardiovascular implantable electronic devices: are there clinical factors that predict success? Pacing. Clin Electrophysiol , 41:524–531
dc.relation.referencesPolyzos KA, K. A. (2015). Risk factors for cardiac implantable electronic device infection: a systematic review and meta-analysis. Europace, 17:767
dc.relation.referencesPrutkin JM, R. M. (2014). Rates of and factors associated with infection in 200 909 Medicare implantable cardioverter-defibrillator implants: results from the National Cardiovascular Data Registry. Circulation , 130:1037
dc.relation.referencesRO, D. (2001). Device-associated infections: a macroproblem that starts with microadherence. Clin Infect Dis , 33:1567–1572
dc.relation.referencesRosso, F. (2016). Infección relacionada con los dispositivos cardiovasculares. Rev. Colomb. Cardiol, vol.23 no.6
dc.relation.referencesRusanov A, S. H. (2010). A 15-year experience with permanent pacemaker and defibrillator lead and patch extractions. Ann Thorac Surg , 89:44–50
dc.relation.referencesSandoe JA, B. G. (2015). Guidelines for the diagnosis, prevention and management of implantable cardiac electronic device infection. Report of a joint Working Party project on behalf of the British Society for Antimicrobial Chemotherapy (BSAC, host organization), British Heart Rh. J Antimicrob Chemother , 70:325–359
dc.relation.referencesSchaerf RHM, N. S. (2016). Percutaneous vacuum-assisted thrombectomy device used for removal of large vegetations on infected pacemaker and defibrillator leads as an adjunct to lead extraction. J Atr Fibrillation , 9:1455
dc.relation.referencesSohail MR, H. C.-F. (2011). Mortality and cost associated with cardiovascular implantable electronic device infections. Arch Intern Med , 171:1821
dc.relation.referencesSohail MR, U. D. (2007). Risk factor analysis of permanent pacemaker infection. Clin Infect Dis, 45:166
dc.relation.referencesSpittell PC, H. D. (1992). Venous complications after insertion of a transvenous pacemaker. . Mayo Clin Proc , 67:258
dc.relation.referencesStarck CT, E.-G. J.-D. (2018). Managing large lead vegetations in transvenous lead extractions using a percutaneous aspiration technique. Expert Rev Med Devices, 15:757–761
dc.relation.referencesSuarez, K. (2019). A Review of Temporary Permanent Pacemakers and a Comparison with Conventional Temporary Pacemakers. J Innov Card Rhythm Manag, 10(5): 3652–3661
dc.relation.referencesTan EM, D. D. (2017). Outcomes in patients with cardiovascular implantable electronic device infection managed with chronic antibiotic suppression. Clin Infect Dis , 64: 1516–1521
dc.relation.referencesTarakji KG, C. E. (2010). Cardiac implantable electronic device infections: presentation, management, and patient outcomes. Heart Rhythm , 7:1043
dc.relation.referencesUslan DZ, S. M. (2007). Permanent pacemaker and implantable cardioverter defibrillator infection: a population-based study. . Arch Intern Med, 67:669–675
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess
dc.subject.proposalInfección
dc.subject.proposaldispositivos cardiacos implantables
dc.subject.proposalfactores de riesgo
dc.subject.proposalscore PADIT
dc.subject.proposalInfection
dc.subject.proposalimplantable cardiac devices
dc.subject.proposalrisk factors
dc.subject.proposalPADIT score
dc.title.translatedPrognostic evaluation of the PADIT score for the prediction of infection associated with Implantable cardiac devices in the Colombian population
dc.type.coarhttp://purl.org/coar/resource_type/c_bdcc
dc.type.coarversionhttp://purl.org/coar/version/c_ab4af688f83e57aa
dc.type.contentText
dc.type.redcolhttp://purl.org/redcol/resource_type/TM
oaire.accessrightshttp://purl.org/coar/access_right/c_abf2
dcterms.audience.professionaldevelopmentEstudiantes
dcterms.audience.professionaldevelopmentMaestros


Archivos en el documento

Thumbnail

Este documento aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del documento

Atribución-NoComercial-SinDerivadas 4.0 InternacionalEsta obra está bajo licencia internacional Creative Commons Reconocimiento-NoComercial 4.0.Este documento ha sido depositado por parte de el(los) autor(es) bajo la siguiente constancia de depósito